Novo Nordisk A/S — Awiqli (insulin icodec-abae) injection 700 u · Type 2 diabetes.
Run-up into the decision (T-120 → T+5)
Daily close, T-120 (10/9/25) through T+5. Run-up high $63.98 on 1/27/26, low $36.33 on 3/25/26 (T-120 to T-1). FDA decision 3/26/26. Historical price action, not a forecast.
Key facts
FDA decision date2026-03-26
OutcomeApproved
Drug / candidateAwiqli (insulin icodec-abae) injection 700 u